11-(10-naphthalen-2-ylanthracen-9-yl)-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1,4,6,8,10,12,14,16,18-nonaene;6-[10-(2,3,4,5,6-pentadeuteriophenyl)anthracen-9-yl]-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1,3(11),4(9),5,7,12,15,17,19-nonaene;12-(10-phenylanthracen-9-yl)-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1(13),2,4,6,8,11,15,17,19-nonaene

C118H68O6 — CID 158723324

IUPAC11-(10-naphthalen-2-ylanthracen-9-yl)-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1,4,6,8,10,12,14,16,18-nonaene;6-[10-(2,3,4,5,6-pentadeuteriophenyl)anthracen-9-yl]-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1,3(11),4(9),5,7,12,15,17,19-nonaene;12-(10-phenylanthracen-9-yl)-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1(13),2,4,6,8,11,15,17,19-nonaene
SMILES[2H]c1c([2H])c([2H])c(-c2c3ccccc3c(-c3ccc4oc5cc6oc7ccccc7c6cc5c4c3)c3ccccc23)c([2H])c1[2H].c1ccc(-c2c3ccccc3c(-c3c4oc5ccccc5c4cc4c3oc3ccccc34)c3ccccc23)cc1.c1ccc2cc(-c3c4ccccc4c(-c4cc5c6ccccc6oc5c5oc6ccccc6c45)c4ccccc34)ccc2c1
InChIInChI=1S/C42H24O2.2C38H22O2/c1-2-12-26-23-27(22-21-25(26)11-1)38-29-14-3-5-16-31(29)39(32-17-6-4-15-30(32)38)35-24-34-28-13-7-9-19-36(28)43-41(34)42-40(35)33-18-8-10-20-37(33)44-42;1-2-12-23(13-3-1)34-26-16-4-6-18-28(26)35(29-19-7-5-17-27(29)34)36-37-30(24-14-8-10-20-32(24)39-37)22-31-25-15-9-11-21-33(25)40-38(31)36;1-2-10-23(11-3-1)37-26-13-4-6-15-28(26)38(29-16-7-5-14-27(29)37)24-18-19-34-30(20-24)32-21-31-25-12-8-9-17-33(25)39-35(31)22-36(32)40-34/h1-24H;2*1-22H/i;;1D,2D,3D,10D,11D
InChIKeyIKEMEUHTABWVBK-CXJNCTIHSA-N
MW1586.87 g/mol
LogP34.53
Rot. Bonds6

About 11-(10-naphthalen-2-ylanthracen-9-yl)-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1,4,6,8,10,12,14,16,18-nonaene;6-[10-(2,3,4,5,6-pentadeuteriophenyl)anthracen-9-yl]-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1,3(11),4(9),5,7,12,15,17,19-nonaene;12-(10-phenylanthracen-9-yl)-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1(13),2,4,6,8,11,15,17,19-nonaene

11-(10-naphthalen-2-ylanthracen-9-yl)-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1,4,6,8,10,12,14,16,18-nonaene;6-[10-(2,3,4,5,6-pentadeuteriophenyl)anthracen-9-yl]-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1,3(11),4(9),5,7,12,15,17,19-nonaene;12-(10-phenylanthracen-9-yl)-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1(13),2,4,6,8,11,15,17,19-nonaene (PubChem CID 158723324) has the molecular formula C118H68O6 and a molecular weight of 1586.87 g/mol. Its IUPAC name is 11-(10-naphthalen-2-ylanthracen-9-yl)-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1,4,6,8,10,12,14,16,18-nonaene;6-[10-(2,3,4,5,6-pentadeuteriophenyl)anthracen-9-yl]-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1,3(11),4(9),5,7,12,15,17,19-nonaene;12-(10-phenylanthracen-9-yl)-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1(13),2,4,6,8,11,15,17,19-nonaene.

Molecular Properties

Compound Name11-(10-naphthalen-2-ylanthracen-9-yl)-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1,4,6,8,10,12,14,16,18-nonaene;6-[10-(2,3,4,5,6-pentadeuteriophenyl)anthracen-9-yl]-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1,3(11),4(9),5,7,12,15,17,19-nonaene;12-(10-phenylanthracen-9-yl)-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1(13),2,4,6,8,11,15,17,19-nonaene
PubChem CID158723324
Molecular FormulaC118H68O6
Molecular Weight1586.87 g/mol
Exact Mass1585.53
IUPAC Name11-(10-naphthalen-2-ylanthracen-9-yl)-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1,4,6,8,10,12,14,16,18-nonaene;6-[10-(2,3,4,5,6-pentadeuteriophenyl)anthracen-9-yl]-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1,3(11),4(9),5,7,12,15,17,19-nonaene;12-(10-phenylanthracen-9-yl)-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1(13),2,4,6,8,11,15,17,19-nonaene
SMILES[2H]c1c([2H])c([2H])c(-c2c3ccccc3c(-c3ccc4oc5cc6oc7ccccc7c6cc5c4c3)c3ccccc23)c([2H])c1[2H].c1ccc(-c2c3ccccc3c(-c3c4oc5ccccc5c4cc4c3oc3ccccc34)c3ccccc23)cc1.c1ccc2cc(-c3c4ccccc4c(-c4cc5c6ccccc6oc5c5oc6ccccc6c45)c4ccccc34)ccc2c1
InChIInChI=1S/C42H24O2.2C38H22O2/c1-2-12-26-23-27(22-21-25(26)11-1)38-29-14-3-5-16-31(29)39(32-17-6-4-15-30(32)38)35-24-34-28-13-7-9-19-36(28)43-41(34)42-40(35)33-18-8-10-20-37(33)44-42;1-2-12-23(13-3-1)34-26-16-4-6-18-28(26)35(29-19-7-5-17-27(29)34)36-37-30(24-14-8-10-20-32(24)39-37)22-31-25-15-9-11-21-33(25)40-38(31)36;1-2-10-23(11-3-1)37-26-13-4-6-15-28(26)38(29-16-7-5-14-27(29)37)24-18-19-34-30(20-24)32-21-31-25-12-8-9-17-33(25)39-35(31)22-36(32)40-34/h1-24H;2*1-22H/i;;1D,2D,3D,10D,11D
InChIKeyIKEMEUHTABWVBK-CXJNCTIHSA-N
XLogP34.53
TPSA78.84 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds6
Heavy Atoms124
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001586.87
LogP ≤ 534.53
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_2', 'substructure': 'N/A'}

Analyze 11-(10-naphthalen-2-ylanthracen-9-yl)-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1,4,6,8,10,12,14,16,18-nonaene;6-[10-(2,3,4,5,6-pentadeuteriophenyl)anthracen-9-yl]-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1,3(11),4(9),5,7,12,15,17,19-nonaene;12-(10-phenylanthracen-9-yl)-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1(13),2,4,6,8,11,15,17,19-nonaene with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 11-(10-naphthalen-2-ylanthracen-9-yl)-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1,4,6,8,10,12,14,16,18-nonaene;6-[10-(2,3,4,5,6-pentadeuteriophenyl)anthracen-9-yl]-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1,3(11),4(9),5,7,12,15,17,19-nonaene;12-(10-phenylanthracen-9-yl)-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1(13),2,4,6,8,11,15,17,19-nonaene?
The IUPAC name of 11-(10-naphthalen-2-ylanthracen-9-yl)-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1,4,6,8,10,12,14,16,18-nonaene;6-[10-(2,3,4,5,6-pentadeuteriophenyl)anthracen-9-yl]-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1,3(11),4(9),5,7,12,15,17,19-nonaene;12-(10-phenylanthracen-9-yl)-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1(13),2,4,6,8,11,15,17,19-nonaene (CID 158723324) is 11-(10-naphthalen-2-ylanthracen-9-yl)-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1,4,6,8,10,12,14,16,18-nonaene;6-[10-(2,3,4,5,6-pentadeuteriophenyl)anthracen-9-yl]-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1,3(11),4(9),5,7,12,15,17,19-nonaene;12-(10-phenylanthracen-9-yl)-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1(13),2,4,6,8,11,15,17,19-nonaene.
What is the SMILES notation for 11-(10-naphthalen-2-ylanthracen-9-yl)-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1,4,6,8,10,12,14,16,18-nonaene;6-[10-(2,3,4,5,6-pentadeuteriophenyl)anthracen-9-yl]-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1,3(11),4(9),5,7,12,15,17,19-nonaene;12-(10-phenylanthracen-9-yl)-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1(13),2,4,6,8,11,15,17,19-nonaene?
The canonical SMILES for 11-(10-naphthalen-2-ylanthracen-9-yl)-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1,4,6,8,10,12,14,16,18-nonaene;6-[10-(2,3,4,5,6-pentadeuteriophenyl)anthracen-9-yl]-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1,3(11),4(9),5,7,12,15,17,19-nonaene;12-(10-phenylanthracen-9-yl)-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1(13),2,4,6,8,11,15,17,19-nonaene is [2H]c1c([2H])c([2H])c(-c2c3ccccc3c(-c3ccc4oc5cc6oc7ccccc7c6cc5c4c3)c3ccccc23)c([2H])c1[2H].c1ccc(-c2c3ccccc3c(-c3c4oc5ccccc5c4cc4c3oc3ccccc34)c3ccccc23)cc1.c1ccc2cc(-c3c4ccccc4c(-c4cc5c6ccccc6oc5c5oc6ccccc6c45)c4ccccc34)ccc2c1.
What is the InChIKey of 11-(10-naphthalen-2-ylanthracen-9-yl)-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1,4,6,8,10,12,14,16,18-nonaene;6-[10-(2,3,4,5,6-pentadeuteriophenyl)anthracen-9-yl]-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1,3(11),4(9),5,7,12,15,17,19-nonaene;12-(10-phenylanthracen-9-yl)-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1(13),2,4,6,8,11,15,17,19-nonaene?
The InChIKey is IKEMEUHTABWVBK-CXJNCTIHSA-N. The full InChI is InChI=1S/C42H24O2.2C38H22O2/c1-2-12-26-23-27(22-21-25(26)11-1)38-29-14-3-5-16-31(29)39(32-17-6-4-15-30(32)38)35-24-34-28-13-7-9-19-36(28)43-41(34)42-40(35)33-18-8-10-20-37(33)44-42;1-2-12-23(13-3-1)34-26-16-4-6-18-28(26)35(29-19-7-5-17-27(29)34)36-37-30(24-14-8-10-20-32(24)39-37)22-31-25-15-9-11-21-33(25)40-38(31)36;1-2-10-23(11-3-1)37-26-13-4-6-15-28(26)38(29-16-7-5-14-27(29)37)24-18-19-34-30(20-24)32-21-31-25-12-8-9-17-33(25)39-35(31)22-36(32)40-34/h1-24H;2*1-22H/i;;1D,2D,3D,10D,11D.
What are the key properties of 11-(10-naphthalen-2-ylanthracen-9-yl)-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1,4,6,8,10,12,14,16,18-nonaene;6-[10-(2,3,4,5,6-pentadeuteriophenyl)anthracen-9-yl]-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1,3(11),4(9),5,7,12,15,17,19-nonaene;12-(10-phenylanthracen-9-yl)-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1(13),2,4,6,8,11,15,17,19-nonaene?
11-(10-naphthalen-2-ylanthracen-9-yl)-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1,4,6,8,10,12,14,16,18-nonaene;6-[10-(2,3,4,5,6-pentadeuteriophenyl)anthracen-9-yl]-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1,3(11),4(9),5,7,12,15,17,19-nonaene;12-(10-phenylanthracen-9-yl)-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1(13),2,4,6,8,11,15,17,19-nonaene has a molecular weight of 1586.87 g/mol, XLogP of 34.53, 6 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 11-(10-naphthalen-2-ylanthracen-9-yl)-3,20-dioxapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1,4,6,8,10,12,14,16,18-nonaene;6-[10-(2,3,4,5,6-pentadeuteriophenyl)anthracen-9-yl]-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1,3(11),4(9),5,7,12,15,17,19-nonaene;12-(10-phenylanthracen-9-yl)-10,14-dioxapentacyclo[11.7.0.03,11.04,9.015,20]icosa-1(13),2,4,6,8,11,15,17,19-nonaene is sourced from PubChem (CID 158723324), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).